| Authors: |
Layman RM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: rlayman@mdanderson.org., Han HS; Moffit Cancer Center, Tampa, FL, USA., Rugo HS; Division of Hematology and Oncology, University of California, San Francisco Comprehensive Cancer Center, San Francisco, CA, USA., Stringer-Reasor EM; Division of Hematology Oncology, Department of Medicine, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Specht JM; Division of Hematology and Oncology, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA., Dees EC; Division of Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Kabos P; Division of Medical Oncology, University of Colorado Hospital, Aurora, CO, USA., Suzuki S; Celcuity, Minneapolis, MN, USA., Mutka SC; Celcuity, Minneapolis, MN, USA., Sullivan BF; Celcuity, Minneapolis, MN, USA., Gorbatchevsky I; Celcuity, Minneapolis, MN, USA., Wesolowski R; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. |
